Calidi Biotherapeutics CLDI
NYSE CLDI
$1.07 +0.01 (+0.94%)
At close: Oct 2, 2026 · 4:00 PM EDT

Calidi Biotherapeutics (CLDI) Non Operating Investment Income (2022 - 2023)

Updated

Calidi Biotherapeutics (CLDI) recorded Non Operating Investment Income of $244,000 in FY2025.

Analysis

Calidi Biotherapeutics (CLDI) Non Operating Investment Income (2022 - 2023) Analysis & Trends

  • Annual Non Operating Investment Income has a four-year compound annual growth rate of 197.5% (FY2021 to FY2025).
  • The FY2025 figure is the lowest annual Non Operating Investment Income since FY2021.
  • Per Business Quant data, CLDI's Non Operating Investment Income was $3,115 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Calidi Biotherapeutics 1.52 Mn -23.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 12,848.00
Mar 31, 2023 27,986.00
Mar 31, 2022 2,266.00
API Access

Calidi Biotherapeutics Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=CLDI&period=max&api_key=YOUR_API_KEY